Predicting Prostate-Specific Antigen Recurrence Established: Now, Who Will Survive?
- 1 August 2002
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (15) , 3188-3190
- https://doi.org/10.1200/jco.2002.20.15.3188
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical ProstatectomyJournal of Clinical Oncology, 2002
- PREDICTING RISK OF PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY WITH THE CENTER FOR PROSTATE DISEASE RESEARCH AND CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR DATABASESJournal of Urology, 2001
- PSA Doubling Time as a Predictor of Clinical Progression After Biochemical Failure Following Radical Prostatectomy for Prostate CancerMayo Clinic Proceedings, 2001
- Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trialsInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate CancerJNCI Journal of the National Cancer Institute, 1998
- Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate CancerJAMA, 1997
- Analysis of Risk Factors for Progression in Patients with Pathologically Confined Prostate Cancers After Radical Retropubic ProstatectomyJournal of Urology, 1996
- Identification of intermediate-risk prostate cancer patients treated with radical radiotherapy suitable for neoadjuvant hormone studiesRadiotherapy and Oncology, 1996
- Prostate-specific antigen and radiation therapy for clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995